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Abstract
Background: In malarious areas of the world, a higher proportion of the population has blood group O than in
non-malarious areas. This is probably due to a survival advantage conferred either by an attenuating effect on the
course of or reduction in the risk of infection by plasmodial parasites. Here, the association between ABO blood
group and incidence of placental malaria was assessed in order to determine the possible influence of the former
on the latter.
Methods: Data from a study in Lambaréné, Gabon, and data from three previously published reports of studies in
The Gambia, Malawi and Sudan, were compiled and compared. ABO blood groups were cross-tabulated with
placental malaria stratified by parity. Odds ratios (OR), stratified by parity, were calculated for the outcome,
placental parasitaemia, and compared between blood group O vs. non-O mothers in all four studies. Random
effects meta-analysis of data from individual studies from areas with perennial hyper/holoendemic transmission
was performed.
Results: In Gabon, the odds ratio (OR) for active placental parasitaemia in mothers with group O was 0.3 (95% CI
0.05-1.8) for primiparae and 0.7 (95% CI 0.3-1.8) for multiparae. The OR for primiparae in the published study from
The Gambia was 3.0 (95% CI 1.2-7.3) and, in Malawi, 2.2 (95% CI 1.1-4.3). In the Sudanese study, no OR for
primiparae could be calculated. The OR for placental parasitaemia in group O multiparae was 0.8 (95% CI 0.3-1.7) in
the Gambia, 0.6 (95% CI 0.4-1.0) in Malawi and 0.4 (95% CI 0.1-1.8) in Sudan. Combining data from the three
studies conducted in hyper-/holo-endemic settings (Gambia, Malawi, Gabon) the OR for placental malaria in blood
group O multiparae was 0.65 (95% CI 0.44-0.96) and for primiparae 1.70 (95% CI 0.67-4.33).
Conclusion: Studies conducted in The Gambia and Malawi suggest that blood group O confers a higher risk of
active placental infection in primiparae, but a significantly lower risk in multiparae. These findings were not
confirmed by the study from Gabon, in which statistically non-significant trends for reduced risk of placental
parasitaemia in those with blood group O, regardless of parity, were observed.
Background
Since the Nobel Prize-rewarded discovery of the ABO
blood group system in 1900 by Karl Landsteiner [1],
many studies have examined the associations between
these blood groups and either infectious or non-infec-
tious diseases [2]. Associations between group A and
gastric cancer and group O and lung cancer have been
demonstrated [3,4]; such diseases, however, primarily
affect humans who have surpassed their reproductive
age and are therefore not expected to influence genetic
selection. In contrast, the death toll from malaria is
highest in children and plasmodial parasites invade ery-
throcytes, the very cells that express the ABO antigens
on their surface. Malaria is thus a disease for which an
association with ABO blood group distribution seems
most plausible, and it may have played an important
role in shaping the prevalence in favour of group O [5].
Supporting evidence for this hypothesis includes i) the
worldwide distribution of the ABO blood groups with a
type O predominance in malarious regions of the world
[6]; ii) the fact that Plasmodium falciparum has substan-
tially affected the human genome [7] and was present
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when the ABO polymorphisms arose [6], iii) the associa-
tions of ABO blood groups and clinical outcome of
malaria, and iv) finally the pathophysiological plausibility
of an interaction between the malaria parasite and the
red blood cell and the potential role erythrocyte surface
antigens may play in cytoadhesion of infected erythro-
cytes and parasite invasion. Numerous studies have been
carried out on the association between the ABO blood
groups and malaria [8], concluding that blood group O
seems to confer a certain degree of protection against
severe courses of the disease [9-12].
Apart from children, pregnant women are particularly
susceptible to infections with P. falciparum. Such infec-
tions during pregnancy affect not only the mother, since
accumulations of infected erythrocytes in the placenta
hamper its function and consequently disturb foetal
development. Adverse outcomes include low birth-
weight, prematurity or even stillbirth. The potential for
selective pressure by P. falciparum, on the ABO blood
groups as well as multiple other genetic loci, is thus
clear. There are few published studies examining the
association between ABO blood groups and placental
malaria [13-15]. In recently published data from the
Gambia and recent data from Malawi, blood group O
was found to be significantly associated with increased
placental malaria infection in primiparae and a reduced
risk of placental malaria infection in multiparae [14,15].
In eastern Sudan, an association between blood group O
and past placental infection was observed in primi- and
in multiparae [13].
Here, using data from a study in Lambaréné, Gabon,
the association between the ABO blood groups and
active placental malaria was investigated and compared
directly with the findings of the other studies published
on this topic.
Methods
Original data were obtained from a study of malaria in
mother-child pairs that was conducted during the period
2003-2004 at the Albert Schweitzer Hospital in Lambar-
éné, Gabon. A comparative analysis was performed, using
these data and three previously published studies, to assess
the effect of blood group O versus non-O on the incidence
of placental malaria in primi- and in multiparae.
Study population and area for the original data collection
Lambaréné is located near to the equator in Central
Africa in an area with perennial malaria transmission.
Data are from a study on malaria and parasitic co-
infections during pregnancy. Further information on
this study was previously published [16,17]. For assess-
ment of the infection status of consecutively enrolled
mothers, placental blood was drawn immediately after
delivery from the intervillous spaces at the centre of
the placental tissue, and Giemsa-stained thick smears
prepared. Parasitaemia was quantified using a standar-
dized microscopical method as previously described
[18]. ABO blood groups were typed by agglutination
using commercially available antiserum-kits. Informed
consent was sought and obtained from all mothers
who were included in the study and additionally from
their parents in the case of minors. The study was
approved by the ethics committee of the International
Foundation of the Albert Schweitzer Hospital.
Data from other studies used for the comparative
analysis
Data from the three published studies were taken from
the original publications. To compare all 4 studies a
dataset was constructed at the individual level (1 set per
mother) consisting of a categorical variable for blood
groups (A, B, AB, and O), a categorical variable indicat-
ing the source study [13-15] and binary variables for
parity (primipara vs. multipara) and placental parasitae-
mia. The outcome variable “placental malaria” was sub-
divided into “acute infection”, defined as the presence of
parasites without pigment, “chronic infection”, defined
as the presence of parasites and pigment, and “past
infection”, defined as the presence of pigment without
parasites. Acute and chronic placental malaria were
grouped as “active infection” [14,19]. For the compari-
son performed here, this latter definition of active pla-
cental malaria was used. Therefore, in the comparison,
the variable “placental parasitaemia” was positive if para-
sites were present either with (chronic infection) or
without (acute infection) pigment. A second study from
Sudan, carried out in close proximity to the first hospi-
tal-based study, was recently published [20], however it
did not contain the detailed data necessary for compari-
son with the others. The main exposure variable of
interest was ABO blood group type. Analyses were car-
ried out using stratification by parity (primi- vs- multi-
para) to account for parity as a potential effect modifier
or a confounder for placental malaria.
Statistical methods
Statistical analyses were conducted using the software
package “STATA 10”. A combined dataset, using pub-
lished data and data from our own study, was generated
in Microsoft Excel. The chi-square or Fisher’s exact test
was used for significance testing of categorical variables
and the Student’s t-test for mean values of continuous
variables. Odds ratios were calculated using logistic
regression with respective 95% confidence intervals.
A meta-analysis generating Forest plots was performed
for those studies providing data from hyper-/holo-ende-
mic settings with stable transmission using a random
effects model.
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Results
Study results from Lambaréné/Gabon
A total of 467 women were included in the study, but for
the analyses performed here data from 91 women, for
whom no placental blood samples had been taken and
from two women for whom the information on the ABO
blood group was missing, were excluded. Therefore the
analytical population consisted of 378 mothers (mean age
24.8, SD 6.5) of whom 84 (22%) were primiparae. The
distribution of the exposure (ABO blood groups) and the
outcome (placental malaria) did not differ significantly
between women who were excluded from the analysis
compared to those who were included (Fisher’s exact test
p = 0.80). However the proportion of primiparae was
slightly lower in the analysed population (22.2%) com-
pared to those excluded (29.7%, Fisher’s exact test p =
0.09, Pearson chi2 p = 0.13). The distribution of blood
group types did not differ significantly in multi- com-
pared to primiparae (p-chi2 = 0.88). The OR for placental
parasitaemia in mothers with blood group O versus non-
O was 0.6 (95% CI 0.3-1.3). When stratified by parity the
respective ORs were 0.3 (95% CI 0.05-1.8) for primiparae
and 0.7 (95% CI 0.3-1.8) for multiparae.
Comparative analysis using data from the three previous
studies and data from Gabon to assess the effect of
blood group O compared to non-O on placental malaria
In The Gambia, the proportion of mothers with blood
group O was 52%, whilst it was 49% in Malawi, 44% in
Sudan and 63% in the present Gabonese study. Thus the
proportion of mothers with blood group O significantly
varies between the countries (Chi2 <0.0001). In the
Gambia, 37.4% of all mothers had active placental parasi-
taemia, compared with 19.3% in Malawi, 4.1% in Sudan
and 7.1% in Gabon. In The Gambia primiparae had a sig-
nificantly higher probability of placental parasitaemia com-
pared to multiparae (47% vs 30%, p = 0.016). None of the
three more recent studies found a significant difference
between primi- and multiparae in this respect. Data
derived from the different studies are shown in Table 1.
The OR stratified by parity for each study were calcu-
lated, and an overview of these is given in Table 2. For
primiparae, two studies showed a clear positive associa-
tion of blood group O and active placental parasitaemia
(OR 3.0, 95% CI 1.2-7.3 & OR 2.2, 95% CI 1.1-4.3). This
association was not reflected in the data from Gabon. In
the study from Sudan, the OR could not be calculated
for primiparae. In multiparae all studies showed a pro-
tective effect of blood group O against placental malaria,
however only in the largest study (647 mothers) was
this effect statistically significant [15]. A second study
from Sudan that is listed in Table S1 (Additional file 1)
was only published as a research note and therefore
does not contain the data required for the analyses pre-
sented in Tables 1 and 2. Based on a random effect
model, a forest plot for the three studies that were car-
ried out in hyper-/holo-endemic regions with stable
transmission (The Gambia, Malawi and Gabon) was
constructed comparing mothers with blood group O to
those with other blood groups with respect to the pre-
sence of active placental infection (Figure 1 and 2). As
parity may be an effect modifier for the effect of ABO
blood group types on placental malaria, the random
effect model was run separately for primi- and multi-
parae. This meta-analysis suggests that blood group O
offers some protection against placental malaria in mul-
tiparae (combined OR 0.65; 95% CI 0.44 - 0.96). In pri-
miparae the opposite effect (blood group O associated
with a higher risk for placental malaria) was noted with-
out reaching statistical significance (combined OR 1.70;
95% CI 0.67 - 4.33). Table S1 (Additional file 1) finally,
gives an overview of all studies that were considered
regarding their location, design, objectives and findings.
Discussion
The OR comparing mothers from Lambaréné with
blood group O to non-O blood groups regarding pla-
cental malaria were 0.3 (95% CI 0.05-1.8) for primiparae
and 0.7 (95% CI 0.3-1.8) for multiparae. These data thus
suggest a tendency towards a protective effect of the
blood group O against placental malaria infection
regardless of parity; however this was not statistically
significant. The higher risk of placental parasitaemia in
primiparae with blood group O that was found in two
previous studies could not be confirmed. The significant
association of blood group O with placental malaria in
primiparae and a reduced risk of placental infection in
multiparae that was found in the recently published
1968 data from the Gambia [14] and a recent study
from Malawi [15] were not confirmed by a study con-
ducted in Sudan [13] or by the study from Gabon. Both
these studies included a smaller sample size than the
study from Malawi and may therefore have lacked the
power to detect an effect. They were nevertheless both
bigger than the older study from the Gambia that, how-
ever, was carried out when the malaria burden was still
much higher than it is now.
Limitations
While other studies used histopathology, the study from
Gabon used placental blood smear. The sensitivity of
histopathology for detection of placental infection is
indeed acknowledged to be greater, although by pre-
cisely how much has not been assessed. Placental blood
smear only allows assessment of active placental malaria
(presence of parasites) and in contrast to histopathology
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cannot detect past infections. Con-sequently only the
association of ABO blood group and active but not past
placental infection was compared in this meta-analysis.
In contrast to other studies, in Gabon there was no dif-
ference in parasite prevalence between primi- and multi-
parae, however it seems unlikely that the absence of a
higher parasitaemia in primiparae could modify the
effect of the analysed exposure (ABO blood group) on
the outcome (placental parasitaemia), especially when
keeping in mind that all analyses were kept stratified by
primi- vs. multiparity. The results from Gabon should
certainly be interpreted with caution as the statistical
power was low with very wide confidence intervals.
Given that only a few studies have been published on
the association between ABO blood groups and placen-
tal malaria, the possibility of publication bias has also to
be born in mind, i.e. other studies have remained
unpublished because no “interesting” relationships
between the ABO blood groups and placental malaria
infection were found. If the severity of pregnancy-asso-
ciated malaria affected the probability of delivering at a
hospital, all studies may bear a selection bias: if blood
group O is associated with less severe courses of disease,
women with more severe courses may not deliver in
Table 1 Placental malaria* and ABO phenotype by parity in different studies
Primiparae Multiparae All
ABO N Plac. Pos.* % N Plac. Pos.* % N Plac. Pos.* %
Loscertales et al. A 16 6 37.5 22 6 27.3 38 12 31.6
Senga et al. A 51 5 9.8 95 21 22.1 146 26 17.8
Adam et al. A 31 2 6.5 51 5 9.8 82 7 8.5
Present study A 18 3 16.7 59 2 3.4 77 5 6.5
Loscertales et al. B 20 6 30.0 32 11 34.4 52 17 32.7
Senga et al. B 50 11 22.0 111 22 19.8 161 33 20.5
Adam et al. B 24 0 0 35 2 5.7 59 2 3.4
Present study B 14 1 7.1 40 6 15.0 54 7 13.0
Loscertales et al. AB 2 0 0 4 2 50.0 6 2 33.3
Senga et al. AB 6 1 16.7 15 5 33.3 21 6 28.6
Adam et al. AB 8 1 12.5 16 0 0 24 1 4.2
Present study AB 2 0 0 7 1 14.3 9 1 11.1
Loscertales et al. O 50 29 58.0 52 14 26.9 102 43 42.2
Senga et al. O 96 28 29.1 213 30 14.1 309 58 18.8
Adam et al. O 51 0 0 77 2 2.6 128 2 1.6
Present study O 50 2 4.0 188 12 6.4 238 14 5.9
Loscertales et al. All 88 41 46.6 110 33 30.0 198 74 37.4
Senga et al. All 203 45 22.2 434 78 18.0 637 123 19.3
Adam et al. All 114 3 2.6 179 9 5.0 293 12 4.1
Present study All 84 6 7.1 294 21 7.1 378 27 7.1
*Acute infection (parasites present without pigment) or chronic infection (parasites present with pigment).
Table 2 Comparing the blood group O vs. non-O regarding placental malaria infection for primi- and multiparae for
four different studies
Primiparae Multiparae Total
N OR 95% CI N OR 95% CI N OR § 95% CI
Loscertales et al. Non-O 38 58 96
O-group 50 3.0 1.2-7.3 52 0.8 0.3-1.7 102 1.5 0.9-2.7
Senga et al. Non-O 107 221 328
O-group 96 2.2 1.1-4.3 213 0.6 0.4-1.0 309 0.9 0.6-1.4
Adam et al. Non-O 63 102 165
O-group 51 # # 77 0.4 0.1-1.8 128 0.3 0.1-1.1
Present study Non-O 34 106 140
O-group 50 0.3 0.1-1.8 188 0.7 0.3-1.8 238 0.6 0.3-1.3
§ If the stratified ORs (for primi- and multiparae) indicate that parity modifies the effect of blood group O on the risk of placental malaria, the combined ORs (for
All) are printed in grey italics as they should not be used for interpretation of the findings.
# In the Adam study there was no active placental parasitaemia in primiparae with blood group O therefore the OR could not be calculated.
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hospital, but rather stay sick at home or even have pre-
mature labour at home. However an inverse effect
would also be credible: women with more severe courses
may have a higher probability of seeking medical sup-
port and therefore deliver in the hospital. To rule out
this bias, longitudinal studies are needed that include
women at the beginning of their pregnancy, assess their
blood groups and follow them up until their delivery,
thus also recording women for whom no placental sam-
ple is available. A limitation of meta analyses that build
on exposure and outcome figures from published studies
is the inability to adjust for further confounding factors
such as maternal age or nutritional status as for such
analyses one would require the corresponding raw data-
sets from all studies. At least information on the most
important effect modifier - parity - could be used and
all analyses were stratified by this factor.
Interpretation and conclusions
In the four studies that were assessed [13-15], between
44% and 63% of mothers had blood group O, a com-
paratively but expectedly high proportion compared to
populations from non-malarious regions in which ~36%
carry this blood group type. This is consistent with a
survival advantage of group O for individuals exposed to
malaria, although the degree of penetration indicates
that non-O types must have some benefit with respect
to other pathogens as they have not been completely
lost [21].
There is conflicting evidence regarding the impact of
ABO blood groups on the probability of malaria infec-
tions of the peripheral blood in non-pregnant indivi-
duals [22-27]. However there seems to be a relative
resistance of blood group O-individuals to severe
courses of the disease [9-12,28] (for a summary see the
review by Uneke [8]).
In theory, it is conceivable that selective pressure
either acts via a blood group- dependent differential risk
of malaria or via a different survival probability when
infected. Previous studies found associations between
blood group O and relatively mild courses of malaria
[9-12] thus indicating a selective pressure acting via a
blood group-dependent differential survival probability.
Under the assumption that blood group O additionally
conferred its survival advantage by reducing the risk of
infection of human beings and blood cells and not by
modifying the course of the disease, one would expect a
protective effect of blood group O against placental
malaria infection. In the four studies that were com-
pared here, three of them in a meta-analysis, some evi-
dence for such a reduced risk of infection conferred by
blood group O could be demonstrated in multiparae.
The hypothesis that the survival advantage of blood
group O with respect to the threat malaria poses is prob-
ably rather due to a milder course of the disease than due
to a lower risk of infection is supported by findings show-
ing that the ABO locus is associated with the serum
levels of molecules known to bind to P. falciparum-
infected red blood cells that are also markers of damage
to vascular endothelial cells and inflammatory processes
such as sE-selectin, sP-selectin and sICAM-1 [29-31].
Furthermore parasitized red blood cells have a stronger
tendency to form rosettes with uninfected erythrocytes of
the A, B or AB blood groups than with those of blood
group O [32-36]. Rosette formation, however, does not
occur with the infected erythrocytes specifically asso-
ciated with placental malaria [35].
Conclusion
In the meta-analysis of four studies a statistically signifi-
cant reduction of placental malaria was observed for
multiparous women with blood group O. For primipar-
ous women no such effect was seen. The blood group O
survival advantage with respect to the threat malaria
poses is probably rather due to a milder course of the
disease than due to a lower risk of infection, although
OR (95% CI) % weight Study 
Loscertales et al. 2006 
Present study 
Senga et al. 2007 
0.76 (0.33, 1.72) 
0.73 (0.30, 1.81) 
0.59 (0.36, 0.98) 





Figure 1 Meta analysis of three different studies from
holoendemic settings on the association between blood group
O vs. other ABO blood groups and active placental infection in
multiparae. Note: The study by Adam et al [20] was excluded from
the meta-analysis as no perennial transmission took place in the
corresponding study site in eastern Sudan.
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OR (95% CI) % weight Study 
Figure 2 Meta analysis of three different studies from
holoendemic settings on the association between blood group
O vs. other ABO blood groups and active placental infection in
primiparae. Note: The study by Adam et al [20] was excluded from
the meta-analysis as no perennial transmission took place in the
corresponding study site in eastern Sudan.
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the data from multiparous women suggest that a lower
risk of infection may also play a role.
Additional material
Additional File 1: Table S1: Studies on the association between ABO
blood groups and placental malaria.
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